Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesPosition statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09
Luz–Rodrigues H et al. – The Expert Panel of the Portuguese Society of Nephrology believes that the safeguard of therapeutic value and safety aspects are mandatory, particularly in biotechnology drugs prescribed for long periods of time. The Panel also believes there is no absolutely safe interchangeability of bioproducts, and that if changes are required this must in all instances be decided by a medical doctor based on solid scientific and clinical data. In this area, financial issues shall on no occasion introduce additional risks to the patient or overcome medical prescription.
Related Articles
Psychotropic Drug Use During Breastfeeding: A Review of the Evidence
Pediatrics, 10/01/09
Relevance Score: 49%
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09
Relevance Score: 48%
Online Illegal Drug Use Information: An Exploratory Analysis of Drug-Related Website Viewing by Adolescents
Journal of Health Communication, 10/29/09
Relevance Score: 47%
Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
AIDS Research and Human Retroviruses, 10/23/09
Relevance Score: 46%
Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09
Relevance Score: 46%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
Expert Review of Anticancer Therapy, 12/07/09
Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: An in vitro study
The International Journal of Artificial Organs, 12/07/09
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
Nephrology Dialysis Transplantation, 12/07/09
Article Search
Sponsor